Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SPECIALTY LABORATORIES INC

NPI: 1811997711 · WEST HILLS, CA 91304 · Clinical Medical Laboratory · NPI assigned 07/21/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official TIMMERMAN, LEAH controls 20+ related entities in our dataset. Read more

$16.76M
Total Medicaid Paid
524,721
Total Claims
426,570
Beneficiaries
179
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTIMMERMAN, LEAH (VICE PRESIDENT)
Parent OrganizationQUEST DIAGNOSTICS INCORPORATED
NPI Enumeration Date07/21/2005

Related Entities

Other providers sharing the same authorized official: TIMMERMAN, LEAH

ProviderCityStateTotal Paid
UNILAB CORPORATION WEST HILLS CA $668.50M
QUEST DIAGNOSTICS INCORPORATED CLIFTON NJ $637.74M
QUEST DIAGNOSTICS LLC IL WOOD DALE IL $429.84M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC IRVING TX $276.76M
LABONE LLC LENEXA KS $212.28M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC TUCKER GA $211.13M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC MIRAMAR FL $197.58M
LABONE OF OHIO INC CINCINNATI OH $167.17M
UNILAB CORPORATION SACRAMENTO CA $141.24M
QUEST DIAGNOSTICS INCORPORATED MD BALTIMORE MD $121.81M
QUEST DIAGNOSTICS INCORPORATED LAS VEGAS NV $59.32M
QUEST DIAGNOSTICS LLC IL SCHAUMBURG IL $50.71M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC TAMPA FL $49.99M
QUEST DIAGNOSTICS NICHOLS INSTITUTE, INC. CHANTILLY VA $46.91M
QUEST DIAGNOSTICS NICHOLS INSTITUTE SAN JUAN CAPISTRANO CA $39.93M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC NORRISTOWN PA $22.72M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC DENVER CO $14.27M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC HOUSTON TX $8.76M
MED FUSION, LLC LEWISVILLE TX $4.17M
QUEST DIAGNOSTICS CLINICAL LABORATORIES INC MARYLAND HEIGHTS MO $2.98M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 173,967 $6.31M
2019 143,294 $5.76M
2020 46,510 $1.02M
2021 46,288 $1.05M
2022 41,165 $946K
2023 55,364 $1.22M
2024 18,133 $446K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87799 67,734 26,147 $4.87M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 28,631 24,520 $1.26M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 31,493 25,455 $1.20M
87512 31,769 25,594 $1.16M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 31,327 24,456 $1.16M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 30,252 24,477 $1.11M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 16,280 14,296 $1.01M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 35,334 29,146 $1.01M
84403 34,617 33,284 $752K
82652 20,398 19,901 $604K
84402 19,013 18,398 $381K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4,393 4,334 $326K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 11,884 11,075 $205K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 1,038 1,037 $176K
84270 7,623 7,293 $126K
84425 8,705 8,185 $124K
86003 4,170 3,453 $75K
86235 1,646 1,456 $74K
84207 4,039 3,742 $71K
80177 6,720 6,252 $63K
83520 7,743 6,977 $63K
84182 888 809 $59K
80180 1,936 1,156 $54K
81329 538 538 $53K
80175 4,400 4,153 $46K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 607 557 $45K
80299 3,668 3,100 $40K
80159 3,972 3,195 $38K
84252 3,900 3,327 $37K
83655 3,865 3,674 $34K
84630 5,611 5,022 $33K
82525 2,867 2,687 $25K
82365 2,857 2,584 $20K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 228 200 $20K
82507 1,246 1,146 $20K
84255 1,383 1,216 $19K
84238 630 601 $18K
82397 2,956 2,736 $17K
82180 3,302 2,831 $16K
84590 1,905 1,797 $15K
80235 1,525 1,297 $13K
80203 1,614 1,452 $13K
84446 1,242 1,163 $12K
83735 2,733 2,440 $12K
86215 2,049 1,965 $12K
82175 1,044 918 $11K
82040 2,417 2,311 $11K
86008 1,097 900 $11K
84591 2,028 1,669 $10K
83825 1,079 954 $10K
83945 1,267 1,171 $10K
80050 General health panel 765 739 $9K
82607 1,573 1,416 $8K
80053 Comprehensive metabolic panel 1,786 1,717 $8K
36415 Collection of venous blood by venipuncture 6,992 6,290 $7K
82570 2,378 2,197 $7K
83516 837 476 $6K
84443 Thyroid stimulating hormone (TSH) 1,019 993 $6K
82140 630 575 $5K
83018 349 272 $5K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 290 283 $5K
82746 1,116 986 $5K
82340 1,250 1,150 $5K
84300 1,459 1,350 $5K
86682 457 457 $5K
86762 356 350 $5K
80061 Lipid panel 1,258 1,225 $4K
87340 526 522 $4K
86803 457 447 $4K
86617 175 175 $4K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,729 1,660 $4K
84105 1,271 1,171 $4K
84392 1,183 1,084 $4K
84560 1,310 1,209 $4K
86480 75 73 $4K
84133 1,276 1,174 $4K
86618 269 267 $4K
82670 511 485 $3K
86592 1,052 1,044 $3K
83036 Hemoglobin; glycosylated (A1C) 1,110 1,071 $3K
86038 476 459 $3K
80201 300 283 $3K
82300 290 225 $3K
86665 109 109 $3K
82728 893 858 $3K
83986 1,241 1,145 $3K
84597 345 325 $3K
86001 961 861 $3K
86255 260 231 $2K
87522 Neg quan hep c or qual rna 74 68 $2K
83001 334 319 $2K
80362 2,927 968 $2K
83785 159 127 $2K
86060 486 486 $2K
84439 598 577 $2K
82657 144 121 $2K
87046 282 278 $1K
86317 104 103 $1K
83540 644 607 $1K
83002 260 250 $1K
87481 27 12 $1K
84481 316 301 $1K
84146 239 226 $1K
84144 237 220 $1K
82495 121 99 $1K
83550 459 446 $1K
82390 211 203 $990.93
86160 65 63 $914.62
87209 87 77 $912.13
87517 25 24 $875.37
86644 78 78 $856.27
86140 271 269 $697.75
80197 103 62 $671.83
82166 70 64 $628.37
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 28 28 $622.00
86696 30 30 $621.20
83970 24 23 $560.23
85027 272 261 $545.86
86695 30 30 $473.04
87177 83 73 $442.18
85652 312 311 $431.97
80361 445 420 $424.96
86645 66 66 $415.71
86376 41 41 $395.04
84480 59 59 $370.03
82784 52 47 $355.36
86431 104 104 $342.81
82785 26 26 $296.66
84153 32 31 $295.68
83525 64 61 $291.85
82542 17 15 $289.05
80365 421 408 $262.18
86200 35 35 $250.05
86039 40 38 $228.67
83615 71 71 $224.96
86704 34 32 $214.50
86361 14 13 $205.39
82105 18 18 $204.30
80356 333 322 $201.18
86780 12 12 $175.27
80165 12 12 $157.18
83874 14 13 $152.25
86787 17 17 $141.32
86706 28 28 $140.42
84436 39 39 $131.66
84550 51 51 $128.56
80048 Basic metabolic panel (calcium, ionized) 34 33 $115.13
81001 101 99 $105.36
86225 12 12 $100.82
86777 13 12 $99.96
82310 67 54 $98.72
80323 18 14 $88.58
82043 82 81 $79.98
80348 365 357 $78.78
83090 15 14 $61.92
84156 34 34 $60.57
84100 16 12 $45.08
86708 12 12 $43.35
85610 28 26 $36.12
82947 14 13 $28.05
82523 75 45 $24.03
80349 31 27 $13.02
87086 Culture, bacterial; quantitative colony count, urine 13 13 $11.30
83921 18 12 $2.07
80332 49 49 $0.00
80369 325 317 $0.00
80355 334 326 $0.00
80346 348 336 $0.00
80366 334 326 $0.00
80354 323 316 $0.00
83992 317 310 $0.00
80373 344 336 $0.00
80360 318 311 $0.00
80372 316 309 $0.00
80358 321 313 $0.00
80324 336 325 $0.00
80374 320 312 $0.00
80368 320 312 $0.00
80353 326 318 $0.00